Skip to content
Surf Wiki
Save to docs
general/macrolide-antibiotics

From Surf Wiki (app.surf) — the open knowledge base

Azalide

Class of antibiotics

Azalide

Class of antibiotics

[[Azithromycin

Azalides are a class of macrolide antibiotics that were originally manufactured in response to the poor acid stability exhibited by original macrolides such as erythromycin. Examples of azalides include azithromycin, which is used in humans, while tulathromycin and gamithromycin are used in veterinary medicine. Following the clinical overuse of macrolides and azalides, ketolides have been developed to combat surfacing macrolide-azalide resistance among streptococci species. Azalides have several advantages over erythromycin such as more potent gram negative antimicrobial activity, acid stability, and side effect tolerability. Although there are few drug interactions with azithromycin, it weakly inhibits the CYP3A4 enzyme.

Structure

Azalides feature a nitrogen atom in their 15-membered macrolide ring, resulting in improved pharmacokinetic properties and greater stability when compared to earlier-generation macrolides. Replacement of the ketone group in traditional macrolides with a tertiary amine group confers greater acid stability. See Beckmann rearrangement.

Mechanism of action

Azalides bind to the bacterial 50S ribosomal subunit and inhibit polypeptide elongation by hindering peptidyl transfer RNA translocation.

Pharmacokinetics

Applicable pharmacokinetic indexes are free azalide AUC24/MIC because of the post antibiotic effect they exhibit, and free azalide concentration/MIC. Due to their large volume of distribution and lipophilic structure, azalides concentrate effectively in tissue.

References

References

  1. (2007-01-01). "Comprehensive Glycoscience".
  2. Pai, Manjunath P.. (2018). "Macrolides, Azalides, and Ketolides". Springer International Publishing.
  3. (2016). "Pharmacodynamics of Macrolides, Azalides, and Ketolides". Springer New York.
  4. Mutak, Stjepan. (February 2007). "Azalides from Azithromycin to New Azalide Derivatives". The Journal of Antibiotics.
  5. Jacobs, Michael R.. (March 2003). "How can we predict bacterial eradication?". International Journal of Infectious Diseases.
Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

Want to explore this topic further?

Ask Mako anything about Azalide — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report